Unbiased AI-powered news
British neobank Revolut is targeting a valuation of $150 billion to $200 billion for its eventual initial public offering, according to reports. The company recently achieved a $75 billion valuation in a secondary share sale, up from $45 billion in 2024. Revolut's CEO stated the IPO remains at least two years away.
Substrate placeholder — needs reviewBritish neobank Revolut is targeting a market capitalization between $150 billion and $200 billion in an initial public offering, the Financial Times reported, citing anonymous investor sources. The company is working on another secondary share sale scheduled for the second half of 2026 that would value it at more than $100 billion, according to PitchBook and the Financial Times.
Revolut was most recently valued at $75 billion in a secondary share sale, up from $45 billion in 2024.
Revolut's co-founder and CEO Nik Storonsky said the company's IPO was at least two years away, according to Bloomberg. The statement came last week. Revolut secured a full banking license in the United Kingdom in March after years of waiting.
Revolut has a banking license in the European Union. Revolut recently applied for a banking license in the United States. The company has received a banking license in Mexico. Revolut launched operations in India in October.
The company is about to start operating in Colombia in 2026. U.S. Founded in 2015, Revolut offers multi-currency accounts, payment and transfer services, crypto products and insurance.
Revolut reported revenue of $6 billion in the financial year ended December 31, 2025, up from $4 billion in 2024. 3 million retail customers at the end of 2025.
“The company’s IPO was at least two years away." — Nik Storonsky, co-founder and CEO of Revolut @techcrunch reported that Revolut declined to comment on the IPO valuation targets. The neobank has been expanding its operations internationally.”
nypost.comSuper PACs tied to Anthropic and OpenAI have spent more than $37 million on congressional primaries this cycle. The groups have outspent candidates in some races and focused on candidates who back differing approaches to AI regulation.
ForbesA longtime public health leader with experience at global health organizations has entered the Democratic primary for New York’s 12th Congressional District. The candidate cited federal public health staffing reductions and an infectious disease outbreak response as reasons for r…